Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

AchromoPhage

Phase 1Biologic

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

Cystic Fibrosis (CF)Recruiting

Cystic Fibrosis (CF)Phase 1

Recruiting

Timeline

Expected Milestones

Q1 2028

Phase 1Recruiting

Cystic Fibrosis (CF)

NCT07275905

Clinical

Trials by Indication[1]

Cystic Fibrosis (CF)1 trial

A Phase 1, Open-label, Randomized, Pilot and Feasibility Trial to Evaluate the Safety and Tolerability of the Achromobacter-targeting Bacteriophage Cocktail, AchromoPhage, Among Persons With Cystic Fibrosis and Chronic Achromobacter Lung Infections: The AchromoPhage Trial

Recruiting·GGhady Haidar·Phase 1·NCT07275905·12 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for AchromoPhage. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — AchromoPhage compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for AchromoPhage. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Ghady Haidar company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Phase 1[1]
Company: GGhady Haidar

Related News